via University of Copenhagen
The receptor responsible for activating the energy-burning property of brown fat in humans has been identified. The next step is to investigate drugs that fit the receptor and trigger the response as a means to treat obesity and type-2 diabetes. The discovery is the result of an international collaboration, including scientists at the University of Copenhagen and Université de Sherbrooke, who published their findings in Cell Metabolism.
An international research team have discovered how to activate brown fat in humans, which may lead to new treatments for type 2 diabetes and obesity. The results of the collaboration between the Centre de recherche du Centre hospitalier universitaire de Sherbrooke (CRCHUS) and the Novo Nordisk Foundation Center for Basic Metabolic Research (CBMR) at the University of Copenhagen were published in Cell Metabolism.
Brown fat burns energy and generates heat – a process called thermogenesis – after being activated by cold temperature or chemical signals. Humans have small deposits of brown fat, and scientists have long hypothesized that finding alternative ways to pharmacologically activate the fat could help improve metabolism.
Scientists have now discovered that beta2-adrenergic receptors (b2-AR) in brown fat cells are responsible for stimulating thermogenesis. According to Dr. Denis Blondin from CRCHUS, the finding could explain why most clinical trials, which have attempted to induce BAT to burn energy, have performed poorly.
“We show that perhaps we were aiming for the wrong target all along. In contrast to rodents, human BAT is activated through the stimulation of the beta2-adrenergic receptor, the same receptor responsible for the release of fat from our white adipose tissue.”
A step toward unlocking the potential of brown fat
According to Associate Professor Camilla Schéele at CBMR, this finding has clear therapeutic applications.
“Activation of brown fat burns calories, improves insulin sensitivity and even affects appetite regulation. Our data reveals a previously unknown key to unlocking these functions in humans, which would potentially be of great gain for people living with obesity or type 2 diabetes”.
A second phase of research will begin in the autumn, which will attempt to validate the finding by activating brown fat with drugs that target b2-AR, explains Professor André Carpentier from CRCHUS:
“Our next step will be to use a drug that specifically activate that target on brown fat and determine how much it could be of use to burn fat and calories in humans. Once this is done, studies in patients with type 2 diabetes will start to determine if this approach can be useful to improve the metabolic control of the disease.”
The international team of scientists responsible for the discovery also include researchers from Leiden University (Netherlands), the Centre for Physical Activity Research at Rigshospitalet (Denmark), the University of Ottawa (Canada), Université Laval (Canada) and Université de Sherbrooke (Canada).
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Belly fat may be resistant to weight loss when intermittent fastingon March 1, 2021 at 9:00 pm
Intermittent fasting is one of the most popular diets, but a new Australian study on mice raises questions about its effectiveness at tackling abdominal fat.
- Brown is the type of fat you actually want on your bodyon February 27, 2021 at 2:14 pm
The good fat that babies are born with actually 'burns up' the bad fat, and so protects us from maladies like type 2 diabetes and heart failure ...
- Gab2 deficiency suppresses high-fat diet-induced obesity by reducing adipose tissue inflammation and increasing brown adipose function in miceon February 26, 2021 at 5:51 am
Obesity is caused by a long-term imbalance between energy intake and consumption and is regulated by multiple signals. This study investigated the effect of signaling scaffolding protein Gab2 on ...
- An improved method for the precise unravelment of non-shivering brown fat thermokineticson February 26, 2021 at 2:30 am
Since the discovery of functional brown adipose tissue (BAT) in adult humans, ... we present a simple yet highly effective and minimally invasive protocol for the Precise Unravelment of Non-shivering ...
- Does the cold burn more fat?on February 25, 2021 at 6:23 am
Exercising in the cold is purported to have a host of health benefits, from strengthening the heart to boosting the immune system. Recent research suggests another benefit: unlocking brown fat cells ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- Salbutamol Market Growth Opportunities, Sales, Revenue, Consumptions, Industry Analysis and Forecasts 2027on March 1, 2021 at 5:10 pm
Global “Salbutamol Market” report is an overview of the global market is provided with prime focus on factors boosting ...
- Beta2-Adrenergic Agonist and Corticosteroid Combinationson March 1, 2021 at 4:01 pm
The product contains fluticasone fumarate, which has shown in vitro to exhibit a binding affinity for the human glucocorticoid receptor that is approximately 29.9 times that of dexamethasone and 1 ...
- The RanBP2/RanGAP1-SUMO complex gates β-arrestin2 nuclear entry to regulate the Mdm2-p53 signaling axison March 1, 2021 at 3:54 am
Shenoy SK, McDonald PH, Kohout TA, Lefkowitz RJ. Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin. Science. 2001;294:1307–13. Wang P ...
- beta2-Adrenergic Receptor Activation and Genetic Polymorphisms in Autism: Data from Dizygotic Twinson February 28, 2021 at 4:00 pm
Spence, MD, PhD; Andrew W. Zimmerman, MD Preterm labor occurs frequently in multiple birth pregnancies and increases the risk of exposure to β 2-adrenergic receptor agonists for tocolysis.
- What you need to know about beta-blockerson February 16, 2021 at 4:00 pm
Other names for beta-blockers include beta-antagonists, beta-adrenergic blocking agents ... in the heart and regulate cardiac activity beta-2 (B2) receptors, which occur in various organs and ...